Sami-Sabinsa Celebrates 35 Years of Innovating Nutraceutical & Cosmeceutical ingredients
Sami-Sabinsa, the globally recognized health science company founded by India Origin Dr. Muhammed Majeed, commemorates its 35th anniversary as it sets the stage for its next phase of expansion.
Originating in 1988 as a humble importer of generic drugs in the US, the company has evolved into an industry leader, particularly in the nutraceutical and cosmeceutical ingredients sector. Diversifying its product lines to include standardized herbal extracts, fine & specialty chemicals, probiotics, and enzymes, Sami-Sabinsa has established itself as a trusted global brand, driven by innovation, scientific evidence, quality, and exceptional service.
The company recently achieved a significant milestone with the inauguration of its state-of-the-art unit-1 manufacturing facility, Sami Nutraceuticals Pvt. Ltd., in Hassan, India. The completion of the unit-2 manufacturing facility is expected by December 2023.
With a workforce of over 1,400 employees across 17 countries, Sami-Sabinsa has expanded its global presence to promising geographies, including the UK, France, Hungary, and Spain. The company’s Intellectual Property (IP) infrastructure spans the U.S.A, Europe, Canada, and India, with over 440 patents supporting its novel ingredients.
Sami-Sabinsa, a pioneer in setting industry standards, holds leadership positions in product lines such as Curcumin C3 Complex®, BioPerine®, and ForsLean®. Recognized for its innovations, the company has recieved numerous awards including the recent 2023 ABC Varro E. Tyler Commercial Investment in Phytomedicinal Research Award from the American Botanical Council and the Best Technology Innovation award for LactoSpore® at the Food Formula Innovation Show in ChengDu, China.
Subscribe to our free newsletter to read the latest news and articles before they are published.